Medullary Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Medullary Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-01-05Clinical Trial Update: A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC). [Phase 3]
A Phase 3 trial comparing pralsetinib to standard of care in RET-mutated medullary thyroid cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-17Clinical Trial Update: Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma [Phase 2]
The Phase 2 clinical trial evaluating Sorafenib for advanced medullary thyroid carcinoma has been withdrawn.